Synapse Open Synapse
Biology

T-Therapeutics reloads with a $133M megaround for bispecifics

BioPharma Dive · · 2 min read

The startup is built around technology it claims can help get after known, but undruggable cancer targets and design particularly selective autoimmune disease treatments.

Latest from BioPharma Dive